EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Twenty‐five years of recombinant human growth factors rhPDGF‐BB and rhBMP‐2 in oral hard and soft tissue regeneration

Maria Elisa Galarraga-Vinueza iD, Shayan Barootchi iD, Marc L Nevins, Myron Nevins, Richard J Miron, Lorenzo Tavelli iD

Periodontology 2000 · 2024-02 · 94 (1) · 483-509

DOI: 10.1111/prd.12522 ↗

At a glance

Übersichtsarbeit in Periodontology 2000, published online on 2023-09-08. Written by Maria Elisa Galarraga-Vinueza and 5 co-authors. Institution: Tufts University School of Dental Medicine, Boston, Massachusetts, USA. Major MEDLINE topics: Becaplermin, Bone Morphogenetic Protein 2, Recombinant Proteins, Proto-Oncogene Proteins c-sis. Cited 53 times so far (Crossref); 182 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Contemporary oral tissue engineering strategies involve recombinant human growth factor approaches to stimulate diverse cellular processes including cell differentiation, migration, recruitment, and proliferation at grafted areas. Recombinant human growth factor applications in oral hard and soft tissue regeneration have been progressively researched over the last 25 years. Growth factor‐mediated surgical approaches aim to accelerate healing, tissue reconstruction, and patient recovery. Thus, regenerative approaches involving growth factors such as recombinant human platelet‐derived growth factor‐BB (rhPDGF‐BB) and recombinant human bone morphogenetic proteins (rhBMPs) have shown certain advantages over invasive traditional surgical approaches in severe hard and soft tissue defects. Several clinical studies assessed the outcomes of rhBMP‐2 in diverse clinical applications for implant site development and bone augmentation. Current evidence regarding the clinical benefits of rhBMP‐2 compared to conventional therapies is inconclusive. Nevertheless, it seems that rhBMP‐2 can promote faster wound healing processes and enhance de novo bone formation, which may be particularly favorable in patients with compromised bone healing capacity or limited donor sites. rhPDGF‐BB has been extensively applied for periodontal regenerative procedures and for the treatment of gingival recessions, showing consistent and positive outcomes. Nevertheless, current evidence regarding its benefits at implant and edentulous sites is limited. The present review explores and depicts the current applications, outcomes, and evidence‐based clinical recommendations of rhPDGF‐BB and rhBMPs for oral tissue regeneration.

Subjects

MeSH terms (MEDLINE)

BecaplerminBone Morphogenetic Protein 2Recombinant ProteinsProto-Oncogene Proteins c-sisTransforming Growth Factor betaHumansBone RegenerationTissue EngineeringGuided Tissue Regeneration, PeriodontalWound Healing

Author keywords

BMP2bone morphogenetic proteinsbone regenerationgrowth factorsimplant regenerationperiodontal regenerationplatelet‐derived growth factorroot coveragescaffoldstissue engineering

Substances

BecaplerminBone Morphogenetic Protein 2Recombinant ProteinsProto-Oncogene Proteins c-sisTransforming Growth Factor betarecombinant human bone morphogenetic protein-2

Authors and institutions

  • Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
  • School of Dentistry, Universidad de las Américas (UDLA), Quito, Ecuador.
  • Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
  • Center for Clinical Research and Evidence Synthesis in Oral Tissue Regeneration (CRITERION), Boston, Massachusetts, USA.
  • Division of Periodontology, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
  • Department of Periodontology, University of Bern, Bern, Switzerland.

ORCID profiles: Maria Elisa Galarraga-Vinueza, Shayan Barootchi, Lorenzo Tavelli

Cite

APA

Galarraga-Vinueza, M. E., Barootchi, S., Nevins, M. L., Nevins, M., Miron, R. J., & Tavelli, L. (2024). Twenty‐five years of recombinant human growth factors rhPDGF‐BB and rhBMP‐2 in oral hard and soft tissue regeneration. Periodontology 2000, 94(1), 483-509. https://doi.org/10.1111/prd.12522

Vancouver

Galarraga-Vinueza ME, Barootchi S, Nevins ML, Nevins M, Miron RJ, Tavelli L. Twenty‐five years of recombinant human growth factors rhPDGF‐BB and rhBMP‐2 in oral hard and soft tissue regeneration. Periodontology 2000. 2024;94(1):483-509. doi:10.1111/prd.12522

BibTeX
@article{GalarragaVinueza2024,
  author = {Galarraga-Vinueza, Maria Elisa and Barootchi, Shayan and Nevins, Marc L and Nevins, Myron and Miron, Richard J and Tavelli, Lorenzo},
  title = {Twenty‐five years of recombinant human growth factors rhPDGF‐BB and rhBMP‐2 in oral hard and soft tissue regeneration},
  journal = {Periodontology 2000},
  year = {2024},
  volume = {94},
  number = {1},
  pages = {483--509},
  doi = {10.1111/prd.12522}
}
Start for free →